Fig. 2From: Effects of adjunctive brexpiprazole on calmness and life engagement in major depressive disorder: post hoc analysis of patient-reported outcomes from clinical trial exit interviewsA Number of life engagement domains that each patient described as being improved; B frequency that specific life engagement domains were described as being improved; and C, D overlap of references to emotional, physical, and social/cognitive engagement domains (n = 105)Back to article page